ReviewDiabetes, obesity & metabolism2026

Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression.

Evangelia E Tsakiridis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.